论文部分内容阅读
自2015年以来,各省逐步开展新一轮药品集中采购工作。随着此项工作的深入推进,一些药品价格方面的怪象逐渐浮出水面,其中最引人关注的就是部分直接挂网药品价格的明显异常上涨。虽然此类药品数量和涉及的企业很少,但在业内却引起了不小的负面效应。以老百姓最为熟悉的抗生素先锋V(注射用头孢唑林钠)为例。按照新一轮省级药品集中采购政策设计,该药品在各省份均被列入直接挂网产品目录,无须经过“双信封”
Since 2015, the provinces have gradually started a new round of centralized procurement of medicines. With the further promotion of this work, some weird aspects of drug prices gradually surfaced. Among them, the most noticeable concern was the notable increase in the price of some drugs directly linked to the net. Although the number of such drugs and the number of involved enterprises are few, they have caused quite a few negative effects in the industry. To the people most familiar antibiotic vanguard V (cefazolin sodium for injection) as an example. According to the new round of centralized purchasing policy of provincial medicine design, the medicine is included in the catalog of direct hanging net in each province, without going through “double envelope”